GGrantIndex
Sort

15,440 grants matching organoids

Core B: PDX/Biospecimen Core

$174,376
Eva Corey · Beth Israel Deaconess Medical Center · P01 · FY2023 · CA

The Gastrointestinal Experimental Model Systems (GEMS) Core

$174,328
Noah Freeman Shroyer · Baylor College Of Medicine · P30 · FY2019 · DK

Core B: PDX/Biospecimen Core

$174,201
Eva Corey · Beth Israel Deaconess Medical Center · P01 · FY2022 · CA

Tissue Procurement and Processing Core

$174,192
Maki Nakayama · University Of Colorado Denver · P30 · FY2024 · DK

Preclinical Models for Cancer Therapeutic Development

$174,117
Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2020 · CA

Preclinical Models for Cancer Therapeutic Development

$174,117
Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2016 · CA

Preclinical Models for Cancer Therapeutic Development

$174,117
Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2019 · CA

Preclinical Models for Cancer Therapeutic Development

$174,117
Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2017 · CA

Preclinical Models for Cancer Therapeutic Development

$174,117
Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2018 · CA

A large animal model to elucidate the role of LGR5 stem cells in cancer

$174,098
Jorge A. Piedrahita · North Carolina State University Raleigh · R21 · FY2022 · CA

New computational, transcriptional, and genome editing approaches to the biology of inflammatory bowel disease

$173,912
Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2020 · DK

Disease Modeling Core

$173,857
Holger A. Russ · University Of Colorado Denver · P30 · FY2023 · DK

A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy

$173,846
Sindy Kam-Yan Tang · Stanford University · R21 · FY2024 · CA

Administrative Core

$173,621
Drew Memmott · University Of Chicago · P30 · FY2024 · CA

PDX Core

$173,597
Kc Kent Lloyd · University Of California At Davis · U54 · FY2025 · CA

Advancing gastric cancer precision medicine in Latinos through patient-derived modeling

$173,597
Luis Guillermo Carvajal Carmona · University Of California At Davis · U54 · FY2025 · CA

Targeting actionable liabilities in Merlin-deficient breast cancer

$173,559
Lalita A. Shevde · University Of Alabama At Birmingham · R21 · FY2024 · CA

Modulating XIAP for the Treatment of Inflammatory Bowel Disease

$173,438
Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AI

Development of resident memory T cells in the synovium

$173,340
Margaret Chang · Boston Children'S Hospital · K08 · FY2022 · AR

Development of resident memory T cells in the synovium

$173,340
Margaret Chang · Boston Children'S Hospital · K08 · FY2023 · AR

Development of resident memory T cells in the synovium

$173,340
Margaret Chang · Boston Children'S Hospital · K08 · FY2024 · AR

Development of resident memory T cells in the synovium

$173,340
Margaret Chang · Boston Children'S Hospital · K08 · FY2025 · AR

Roles of Glycoslyation in Notch Signaling

$173,318
Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2018 · GM

Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies

$173,208
Michael J Toth · University Of Vermont & St Agric College · R21 · FY2024 · CA

Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention

$173,208
Grace Y. Chen · University Of Michigan At Ann Arbor · R21 · FY2024 · CA